A Phase 3, randomised, open-label, cross-over study to compare HFA vs CFC pMDI formulations of budesonide on methacholine hyper-reactivity in patients with stable, persistent, mild to moderate asthma

Update Il y a 4 ans
Reference: EUCTR2007-006249-42

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective is to compare the relative dose potency of HFA vs CFC pMDI budesonide on airway responsiveness to methacholine.


Inclusion criteria

  • Asthma

Links